U.S. Pharmaceutical Sales - Q1 2012

The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q1 2012. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.

Last updated: February 2014 (updated quarterly).

Top 100 Drugs for Q1 2012 by Sales

Rank Drug Sales ($000)
1 (1) Plavix
Bristol-Myers Squibb Company
2.85% Stats
2 (1) Nexium
AstraZeneca Pharmaceuticals, LP
-3.08% Stats
3 (1) Abilify
Otsuka Pharmaceutical Co., Ltd
4.46% Stats
4 (1) Singulair
Merck & Co., Inc.
8.67% Stats
5 (1) Seroquel
AstraZeneca Pharmaceuticals, LP
3.29% Stats
6 (1) Advair Diskus
GlaxoSmithKline
1.61% Stats
7 (1) Crestor
AstraZeneca Pharmaceuticals, LP
2.35% Stats
8 (1) Cymbalta
Eli Lilly and Company
7.58% Stats
9 (15) atorvastatin
Generic
88.56% Stats
10 Humira
AbbVie, Inc.
2.50% Stats
11 (2) Remicade
Centocor Ortho Biotech, Inc
10.04% Stats
12 (1) Enbrel
Amgen Inc.
1.92% Stats
13 (1) Neulasta
Amgen Inc.
3.33% Stats
14 (13) Lipitor
Pfizer Inc
-47.51% Stats
15 (1) Rituxan
Genentech, Inc (member of Roche group)
-1.91% Stats
16 Copaxone
Teva Pharmaceuticals
4.59% Stats
17 (2) Atripla
Gilead Sciences, Inc.
5.61% Stats
18 (1) OxyContin
-1.05% Stats
19 (3) Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc
8.12% Stats
20 (1) Avastin
Genentech, Inc (member of Roche group)
-1.92% Stats
21 (3) Actos
Takeda Pharmaceuticals U.S.A., Inc
-4.52% Stats
22 (1) Januvia
Merck & Co., Inc.
7.89% Stats
23 (2) Truvada
Gilead Sciences, Inc.
8.31% Stats
24 (3) Lantus
Sanofi (formerly Sanofi Aventis)
9.78% Stats
25 (3) Diovan
Novartis Corporation
12.44% Stats
26 (11) Lexapro
Forest Pharmaceuticals, Inc
-31.67% Stats
27 (7) Epogen
Amgen Inc.
-24.54% Stats
28 (3) Lyrica
Pfizer Inc
6.04% Stats
29 (5) Lantus Solostar
Sanofi (formerly Sanofi Aventis)
9.81% Stats
30 (4) enoxaparin
Generic
-8.30% Stats
31 (4) Eloxatin
Sanofi (formerly Sanofi Aventis)
8.38% Stats
32 Celebrex
Pfizer Inc
1.08% Stats
33 Herceptin
Genentech, Inc (member of Roche group)
-0.06% Stats
34 (6) Diovan HCT
Novartis Corporation
9.52% Stats
35 (5) Lucentis
Genentech, Inc (member of Roche group)
-6.89% Stats
36 (15) Synagis
MedImmune, Inc
38.30% Stats
37 Namenda
Forest Pharmaceuticals, Inc
2.71% Stats
38 (2) Gleevec
Novartis Corporation
0.13% Stats
39 (1) Avonex
Biogen Idec
2.22% Stats
40 (3) Vyvanse
Shire US Inc
11.05% Stats
41 (2) olanzapine
Generic
1.70% Stats
42 (13) Incivek
Vertex Pharmaceuticals
-16.88% Stats
43 (1) OneTouch
1.32% Stats
44 Suboxone
Reckitt Benckiser Pharmaceuticals Inc.
2.14% Stats
45 (5) methylphenidate
Generic
11.27% Stats
46 Zetia
Merck & Co., Inc.
2.67% Stats
47 (6) AndroGel
AbbVie, Inc.
11.20% Stats
48 (1) Provigil
Cephalon, Inc. (a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd)
-3.18% Stats
49 Lidoderm
Endo Pharmaceuticals
-2.46% Stats
50 (2) TriCor
Abbott Laboratories
-4.37% Stats
51 (5) Symbicort
AstraZeneca Pharmaceuticals, LP
8.71% Stats
52 Combivent
Boehringer Ingelheim Pharmaceuticals, Inc
1.08% Stats
53 (16) ProAir HFA
Teva Pharmaceuticals
18.08% Stats
54 (5) Seroquel XR
AstraZeneca Pharmaceuticals, LP
7.81% Stats
55 (1) amphetamine/dextroamphetamine
Generic
-1.02% Stats
56 (8) Nasonex
Merck & Co., Inc.
9.21% Stats
57 (6) Novolog
Novo Nordisk, Inc.
5.67% Stats
58 (3) Procrit
Janssen Pharmaceuticals, Inc
-2.13% Stats
59 (1) Alimta
Eli Lilly and Company
1.24% Stats
60 (2) Viagra
Pfizer Inc
1.22% Stats
61 (16) Geodon
Pfizer Inc
-21.06% Stats
62 (1) Rebif
-0.21% Stats
63 (6) budesonide
Generic
-3.57% Stats
64 (6) Niaspan
Abbott Laboratories
-3.28% Stats
65 Humalog
Eli Lilly and Company
-2.70% Stats
66 (1) Flovent HFA
GlaxoSmithKline
-1.45% Stats
67 (1) Lovaza
GlaxoSmithKline
-1.81% Stats
68 (7) Levemir
Novo Nordisk, Inc.
9.25% Stats
69 (5) Adderall XR
Shire US Inc
5.88% Stats
70 Neupogen
Amgen Inc.
0.06% Stats
71 (1) Reyataz
Bristol-Myers Squibb Company
1.45% Stats
72 (6) Aranesp
Amgen Inc.
-5.86% Stats
73 metoprolol
Generic
-0.53% Stats
74 (2) NovoLog FlexPen
Novo Nordisk, Inc.
8.96% Stats
75 (4) Vytorin
Merck & Co., Inc.
-7.25% Stats
76 (7) Janumet
Merck & Co., Inc.
8.76% Stats
77 (1) Isentress
Merck & Co., Inc.
2.46% Stats
78 () escitalopram
Generic
Stats
79 (1) Cialis
Eli Lilly and Company
3.24% Stats
80 (3) Aciphex
Eisai Corporation
-1.77% Stats
81 (4) Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc
5.13% Stats
82 (2) Solodyn
Medicis Pharmaceutical Corporation
2.06% Stats
83 (4) fentanyl
Generic
-3.34% Stats
84 (43) Zyprexa
Eli Lilly and Company
-48.69% Stats
85 (4) Velcade
Takeda Pharmaceuticals U.S.A., Inc
4.42% Stats
86 Restasis
Allergan, Inc
-1.18% Stats
87 (5) Lunesta
Sunovion Pharmaceuticals Inc.
-4.30% Stats
88 (1) acetaminophen/hydrocodone
Generic
0.09% Stats
89 (9) Prezista
Janssen Pharmaceuticals, Inc
9.20% Stats
90 (1) Pegasys
Genentech, Inc (member of Roche group)
3.92% Stats
91 (2) Zyvox
Pfizer Inc
3.85% Stats
92 (4) Prevnar 13
Wyeth
-1.16% Stats
93 (12) Lovenox
-9.21% Stats
94 Benicar
Daiichi Sankyo
2.79% Stats
95 (5) VESIcare
Astellas Pharma US
6.58% Stats
96 () Ventolin HFA
GlaxoSmithKline
Stats
97 () Orencia
Bristol-Myers Squibb Company
Stats
98 (1) Betaseron
Bayer Healthcare Pharmaceuticals
2.93% Stats
99 (2) Erbitux
Bristol-Myers Squibb Company
2.30% Stats
100 () Dexilant
Takeda Pharmaceuticals U.S.A., Inc
Stats

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Hide
(web1)